Zhejiang Tianyu Pharmaceutical (300702.SZ)Pregabalin Capsules Obtained Drug Registration Certificate
Tianyu Group (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode...
Zhejiang Tianyu Pharmaceutical (300702.SZ) announced that its wholly-owned subsidiary Zhejiang Nuode Pharmaceutical Co., Ltd. (referred to as "Nuode Pharmaceutical") recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Prugabalin Capsules.
The announcement stated that Prugabalin Capsules are used to treat postherpetic neuralgia and fibromyalgia, a medication for postherpetic neuralgia.
Related Articles
KO YO GROUP (00827) issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately 146 million yuan, a year-on-year decrease.
The Paradigm and Huaxia Finance have established an arrangement for the repurchase and leaseback of servers, revitalizing computing power assets to empower the long-term development of the business.
AHSAY BACKUP (08290) released its interim results, reporting a loss attributable to equity holders of HK$94,000, a decrease of 48.07% year-on-year.
KO YO GROUP (00827) issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately 146 million yuan, a year-on-year decrease.
The Paradigm and Huaxia Finance have established an arrangement for the repurchase and leaseback of servers, revitalizing computing power assets to empower the long-term development of the business.
AHSAY BACKUP (08290) released its interim results, reporting a loss attributable to equity holders of HK$94,000, a decrease of 48.07% year-on-year.
RECOMMEND
